-+ 0.00%
-+ 0.00%
-+ 0.00%

NUVATION BIO GRANTED FDA FAST TRACK DESIGNATION FOR SAFUSIDENIB FOR TREATMENT OF IDH1-MUTANT GLIOMA

Reuters·08/20/2026 12:00:04

Please log in to view news